Cenduit is sponsoring 2nd Annual Interactive Response Technologies (IRT) for Clinical Trials Conference in Philadelphia, US.
The Conference, which will be held from 8-9 November, will discuss how to avoid risks of patient or material unblinding when defining drug supply specifications of interactive response technology (IRT) systems.
Cenduit project management associate director and IRT expert Stefan Dürr will discuss factors that must be considered as part of a well-designed drug supply strategy in an IRT system,including creating appropriate material lists, examining resupply calculation options, defining the selection method for assigning the drug to shipments and patients and managing drugs from different packaging campaigns.
"Without a well-planned drug supply strategy, the risk of partial or full unblinding events increases," Dürr added.
Cenduit serves more than 16,000 sites in more than 100 countries and offers IRT solutions that include patient randomization, drug supply management, drug allocation, drug accountability, custom reporting and eClinical integration.
